Drug Delivery Innovation

We support innovation projects, NPI activities, and portfolio management activities for value enhancement products (VEPs) which includes drug delivery devices, combination products, companion diagnostics, and digital health products. VEPs complement and enhance the value profile and positioning of the underlying asset, often creating new value by improving patient-reported outcomes.

Our proprietary methodology creates a data-driven connection between the drug and device worlds, translating the needs of the drug world into actional strategic insights for VEP projects and portfolio management activities.

We do this using a Value Dashboard™, which enables robust decision-making under uncertainty. You can read more about Value Dashboards or get in touch for more information.